ARMEN GARO H has demonstrated a consistent and exclusive focus on acquiring shares of Agenus Inc. (AGEN), with no recorded sales across 42 transactions totaling $1,356,207 in buy activity. The trading pattern reveals a disciplined, near-monthly accumulation of AGEN shares from January 2025 through March 2026, with each purchase tightly clustered between $14,776 and $16,358 per transaction. Notably, the investment rhythm shifted in late 2025, with transaction values decreasing from the ~$16,300 range seen between August and December 2025 to ~$14,800 in early 2026, suggesting either a price adjustment or modified acquisition strategy. The most recent purchases occurred on March 6 and 20, 2026, at $14,782 and $14,777 respectively, maintaining the lower value tier observed since January 2026. All transactions were coded as open market or derivative acquisitions (Code A), with no option exercises or indirect holdings reported. The absence of any sell-side activity across the 14-month observation period indicates a singular accumulation strategy concentrated solely in AGEN, though the "See Remarks" officer title leaves the precise nature of H's relationship to the company unspecified in the filings.
AI-assisted summary